What is the ticker symbol for MaxCyte?

MaxCyte trades under the ticker MXCT on NASDAQ.

What sector does MaxCyte operate in?

MaxCyte is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze MXCT in a portfolio?

PortView shows MXCT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

MaxCyte (MXCT) Stock Analysis

NASDAQHealthcareBiotechnology

$1.24+0.40%

1-year price historyRange $0.68 – $1.83

52-week range$1.24

$0.64$1.87

What MaxCyte does

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.

Key metrics

Market cap

$132.83M

P/E (TTM)

-4.13

EPS (TTM)

$-0.30

Beta

1.49

Dividend yield

0.00%

Revenue / share

$0.29

50-day avg

$1.24

200-day avg

$1.13

52-week high

$1.87

52-week low

$0.64

CEO

Maher Masoud

ETFs linked to MXCT

Broad-market and Healthcare sector ETFs an investor holding MaxCyte is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how MXCT fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze MXCT in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for MaxCyte?: MaxCyte trades under the ticker MXCT on NASDAQ.
Which exchange is MXCT listed on?: MXCT is listed on NASDAQ.
What sector does MaxCyte operate in?: MaxCyte is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze MXCT in a portfolio?: PortView shows MXCT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.